BioSpace

GSK pledges $800M to add biologics production capabilities in Pennsylvania

Starting next year, GSK plans to demolish existing buildings and construct new facilities to support clinical and commercial supply. The investment will create more than 300 new jobs over the next five years, Pennsylvania state officials said.

By BioSpace

1 min read
GSK pledges $800M to add biologics production capabilities in Pennsylvania
AI-generated illustration

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

Related Insights